Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research for Healthier Aging . CECAD Cologne – Cologne Cluster of Excellence on Age Research presented itself

29.01.2008
Increasing life expectancy means the society is faced with an increased risk of aging-associated diseases, e.g. obesity, diabetes, atherosclerosis, cancer, and neurodegenerative diseases.

Research on the treatment and prevention of these illnesses therefore belongs to one of the most important medical issues of the future. The Cologne Excellence Cluster CECAD Cologne (Cellular Stress Responses in Aging-Associated Diseases) made it its objective to gain a better understanding of the molecular mechanisms underlying lifespan regulation and aging-associated diseases in order to achieve its long-term objective of developing new therapeutic interventions.

The Cologne Excellence Cluster (CECAD Cologne), which will receive over six million euros annually within the framework of the Excellence Initiative, will bring together researchers and clinicians from the University of Cologne and the University Hospital with researchers from the new Max Planck Institute for Biology of Aging. This constellation makes the CECAD-Cologne the first ever research center in Europe to dedicate itself solely to discovering the underlying mechanisms of aging along with those triggering aging-associated diseases.

It is therefore envisioned that this cluster will become an internationally recognized leader at the forefront of aging research paving the way for the development of preventive and novel therapeutic interventions. "Cologne is the epicenter of an excellent regional health care service continually demonstrating outstanding competence in the areas of science and research,” said Cologne’s Lord Mayor Fritz Schramma, who started the initiative "Health Cologne" in association with the University of Cologne and other health care authorities last year. Lord Mayor Schramma also said, "With the Excellence Cluster CECAD-Cologne, Cologne’s health care will become a leading center in the domain of "Gesundheit für Generationen (Health for the Generations)”, which is increasingly important for future development – not only for Cologne.”

The University Rector Prof. Dr. Axel Freimuth also pointed out: “Through CECAD-Cologne, we have yet another beacon in our profile domain of life sciences.” We hereby cordially invite you to the press conference on the occasion of the official presentation of the CECAD-Cologne.

The following parties will be taking part in the press conference:
-University-Rector Prof. Dr. Axel Freimuth,
-Lord Mayor Fritz Schramma,
-CECAD-Speaker Prof. Dr. Jens Brüning,
-Prof. Dr. Michael Hallek, Chair Person of the Center for Integrated Oncology, and

-Prof. Dr. Thomas Langer, Speaker for the Collaborative Research Center 635 (Posttranslational Control of Proteins).

Place: University of Cologne, Main Building, Alter Senatssaal

Time: 12:45-13:45, 7th February 2008

Patrick Honecker | alfa
Further information:
http://www.cecad.uni-koeln.de/

More articles from Health and Medicine:

nachricht UIC researchers find unique organ-specific signature profiles for blood vessel cells
18.02.2020 | University of Illinois at Chicago

nachricht Remdesivir prevents MERS coronavirus disease in monkeys
14.02.2020 | NIH/National Institute of Allergy and Infectious Diseases

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Journey to the center of Mars

20.02.2020 | Physics and Astronomy

Laser writing enables practical flat optics and data storage in glass

20.02.2020 | Physics and Astronomy

New graphene-based metasurface capable of independent amplitude and phase control of light

20.02.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>